FDA Inspection 963077 — Carter BloodCare At Grand Prairie
The FDA completed an inspection of Carter BloodCare At Grand Prairie on Mar 11, 2016 in Grand Prairie, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 11, 2016
- Fiscal Year
- 2016
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Grand Prairie, TX (United States)